AzTrials
AzTrials

Brain InjuryS100NCT02650765

S100 Biomarker in the Acute Management of Mild Head Injuries

An observational study of Brain Injury and Head Injury, run by Tampere University Hospital at 1 site in Finland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A prospective validation study of the "Scandinavian guidelines for initial management of minimal, mild and moderate head injuries in adults". Enrolling a consecutive sample of 1000 adult head injury patients from the emergency department of the Tampere University Hospital (Tampere, Finland). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Brain Injury, Head Injury
What is being tested?
Indications for head CT imaging after acute head injury
How many people
295 participants
Where
1 siteFinland
Study dates
Nov 2015to Feb 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: A consecutive sample of adult patients with an acute head injury whom are treated at the emergency department of the Tampere University Hospital, Tampere, Finland

Who may be able to join

  • Head injury

Who cannot join

  • Age under 18 years

Trial locations and contacts

1 site in 1 country.

Finland1 site
  • Tampere University Hospital

    Tampere, 33521

Other trials in Finland

About this study

A prospective validation study of the "Scandinavian guidelines for initial management of minimal, mild and moderate head injuries in adults". Enrolling a consecutive sample of 1000 adult head injury patients from the emergency department of the Tampere University Hospital (Tampere, Finland). A venous blood sample with S100 analytics (+storage blood) is drawn from every patient. The patients are head CT-scanned according to the SNC guidelines. Outcome assessment (GOSE, MRS, Rivermead PCS Questionnaire) is completed as follows: 1 week, 6 months, 1 year, and 2 years.

Read the detailed description

A prospective clinical head injury study conducted at the Emergency Department of the Tampere University Hospital, which is situated in Tampere, Finland. The hospital takes care of an catchment area of 524 447 inhabitants both from urban and rural areas. About 100 000 patients are treated in the Emergency department annually.

The study aims to improve the emergency evaluation of patients with an acute head injury, especially a mild head injury. About 80% of head CT scan performed on head injury patients in the Emergency Department of the Tampere University Hospital are negative (= no acute traumatic lesion). There is an urgent need to update the head CT imaging criteria/indications in the context of acute head injury in order to reduce the number of unnecessary scanning. More selective head CT indications result in considerable health care savings and decreased exposure to ionizing radiation, among other benefits.

In this study, the investigators implement the "Scandinavian guidelines for initial management of minimal, mild and moderate head injuries in adults" criteria as part of the emergency care of adults head injury patients. By enrolling a large consecutive sample of patients the investigators are validating this new guideline. Emergency department assessment data is combined with long-term outcome parameters and blood-based biomarkers of neurotrauma.

The main aims of the study are:

  1. the validation of the Scandinavian guidelines for initial management of minimal, mild and moderate head injuries in adults
  2. the examination of novel blood-based biomarkers of acute brain injury that correlate with the radiological severity of the injury and the long-term outcome
Being tested
Indications for head CT imaging after acute head injury
Keywords
Brain injury, Head injury, Computed tomography, Emergency department
Medical subject headings
Brain Injuries, Craniocerebral Trauma, Emergencies

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Indications for head CT imaging after acute head injuryOther

    Indications for head CT imaging after acute head injury as per the Scandinavian guidelines for initial management of minimal, mild and moderate head injuries in adults.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Non-contrast head CT

    Head CT findings: Intracranial traumatic lesions

    Measured: 0-72h

Secondary outcomes (3)
  1. Glasgow Outcome Scale Extended

    Glasgow Outcome Scale Extended

    Measured: 1 week, 6 months, 1 year, and 2 years

  2. Modified Rankin Scale

    Modified Rankin Scale

    Measured: 1 week, 6 months, 1 year, and 2 years

  3. Rivermead PCS Questionnaire

    Rivermead PCS Questionnaire

    Measured: 1 week, 6 months, 1 year, and 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jan 2016 (estimated)
  2. Study startNov 2015
  3. Primary completionFeb 2021
  4. Study completionFeb 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
295 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02650765
Sponsor's protocol ID
R15045
Acronym
S100
Status last verified
Oct 2021
First submitted
22 Dec 2015
Last updated
6 Oct 2021
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Brain Injury and Head Injury, run by Tampere University Hospital at 1 site in Finland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Finland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Non-contrast head CT (time frame: 0-72h). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Oct 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in